Compare WTS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WTS | ICLR |
|---|---|---|
| Founded | 1874 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.3B |
| IPO Year | 1994 | 2001 |
| Metric | WTS | ICLR |
|---|---|---|
| Price | $297.30 | $125.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $335.00 | $178.62 |
| AVG Volume (30 Days) | 224.6K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 17.03 | N/A |
| EPS | ★ 2.97 | N/A |
| Revenue | ★ $2,438,500,000.00 | N/A |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | $5.72 | N/A |
| P/E Ratio | $29.18 | ★ $12.91 |
| Revenue Growth | ★ 8.27 | N/A |
| 52 Week Low | $235.14 | $66.57 |
| 52 Week High | $345.17 | $211.00 |
| Indicator | WTS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 62.35 |
| Support Level | $287.81 | $99.11 |
| Resistance Level | $308.45 | $193.87 |
| Average True Range (ATR) | 8.87 | 6.49 |
| MACD | -0.31 | 1.65 |
| Stochastic Oscillator | 33.02 | 83.93 |
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.